What is driving the pre-market activity in 4564.T stock?

Pre-market activity in 4564.T stock is driven by elevated volume of **34,217,200.00** and anticipation of clinical updates and funding news. In clinical biotechs, newsflow often concentrates trading before the cash market opens.

How does OncoTherapy's valuation look versus peers?

OncoTherapy (4564.T stock) shows high price-to-sales **9.20** and price-to-book **3.54**, which are rich relative to larger healthcare peers. The company remains loss-making with EPS **-2.83**, so comparatives depend heavily on trial outcomes.

What is Meyka AI's short-term forecast for 4564.T stock?

Meyka AI's forecast model projects a monthly price of **JPY 16.39** and a one-year projection of **JPY 18.02** for 4564.T stock. These are model projections and not guarantees; downside versus the current price is about **-14.10%** for the one-year figure.

JP Stocks

Pre-market most active 4564.T OncoTherapy (JPX) JPY 21.00 Feb 2026: watch vol

ByHuzaifa Zahoor February 25, 2026

In the pre-market session we see 4564.T stock trading at JPY 21.00, with heavy volume that places the name among the most active issues on the JPX today. Volume is already at 34,217,200.00, well above typical intraday flows and above the 50-day average price of 20.96. Traders cite near-term clinical and funding updates as the likely drivers. We provide a concise pre-market read on valuation, technical setup, and analyst-relevant metrics to help frame early trading decisions.